ABOS vs ONMD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 04, 2026

ABOS

46.0
AI Score
VS
ABOS Wins

ONMD

34.2
AI Score

Investment Advisor Scores

ABOS

46score
Recommendation
HOLD

ONMD

34score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ABOS ONMD Winner
Net Income -53.45M -2.80M ONMD
Operating Income -53.70M -9.67M ONMD
ROE -93.3% 94.5% ONMD
ROA -46.1% -130.2% ABOS
Total Assets 116.01M 2.15M ABOS
Cash 59.44M 585,000 ABOS
Debt/Equity 0.21 -0.07 ONMD
Current Ratio 2.47 0.43 ABOS

Relative Price Performance (Last 90 Days)

ABOS 1M: -34.2% · 3M: -23.6% ONMD 1M: +848.9% · 3M: +665.1%

Current Technical Phase

ABOS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 30

RSI (14): 29.8 · Price: $2.04

ONMD

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (56.2% over 20 days), RSI 89

RSI (14): 89.1 · Price: $5.39

Fundamentals Snapshot

Metric ABOS ONMD
Market Cap — —
Forward P/E -1.4 0.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.9%
Gross Margin -263.8% -0.8%
Operating Margin 0.0% -7.7%
EPS -1.64 -1.61
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ABOS is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.